Claris Lifesciences down 8 pc on BSE

MUMBAI: Drug firm Claris Lifesciences listed at 224.4 rupees on the BSE on Monday, down 1.57 percent from its issue price of 228 rupees a share.

Claris sold 10.78 million shares through its initial public offer ( IPO) issue to raise 2.46 billion rupees.

Enam Securities, Edelweiss Capital, JM Financial Consultants and ICICI Securities were the arrangers to the issue.

At 9:28 a.m., shares were trading at 210.7 rupees rupees, down 7.58 percent in a weak Mumbai market.